June 11 (Reuters) - Novartis said on Thursday an experimental drug, which it acquired as part of its $12 billion takeover of ...

Novartis (NVS) says its RNA therapy braxlosiran (del-brax), added from its $12B acquisition of Avidity Biosciences in February, succeeded in a Phase 1/2 trial for facioscapulohumeral muscular ...

Different types of liver disease are leading to distinct signatures of muscle loss, according to a new study that could help pave the way for more personalized treatments for sarcopenia in people with ...

University of Maine researchers have published new findings about how muscles form, why certain muscle diseases develop and ...

University of Maine researchers have published new findings about how muscles form, why certain muscle diseases develop and ...

Biomedical engineers have grown muscles in a lab to better understand and test treatments for a group of extremely rare muscle disorders called dysferlinopathy or limb girdle muscular dystrophies 2B ...

The musician shares an update on his battle with the muscle disease inclusion body myositis, which he's been living with ...

Peter Frampton, 76, discusses living with Inclusion Body Myositis, a rare, progressive muscle disease that is changing how he ...

I've been blogging for a few years about misophonia, an auditory/neurological disorder that I have advocated for because I and (more importantly) one of my adult children are affected. Recently, at ...

Musculoskeletal (MSK) disorders affect the muscles, bones, joints, and tissues. In children, they may be due to infection, cancer, inflammatory arthritis, or progressive muscle disorders. MSK ...